Insider Transactions in Q3 2023 at Predictive Oncology Inc. (POAI)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 25
2023
|
Robert L Myers CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
510
-9.75%
|
$1,020
$2.96 P/Share
|
|
Sep 25
2023
|
Robert L Myers CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,667
+24.17%
|
-
|
|
Sep 25
2023
|
Charles Lee Sr Nuzum Director |
SELL
Open market or private sale
|
Direct |
10,000
-29.38%
|
$30,000
$3.04 P/Share
|
|
Jul 03
2023
|
Clair Gregory Sr St. Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,773
+19.02%
|
-
|
|
Jul 03
2023
|
Charles Lee Sr Nuzum Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,773
+9.98%
|
-
|
|
Jul 03
2023
|
Nancy Chung Welch Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,675
+15.06%
|
-
|
|
Jul 03
2023
|
Daniel E Handley Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,675
+17.3%
|
-
|
|
Jul 03
2023
|
Matthew Hawryluk Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,675
+33.71%
|
-
|
|
Jul 03
2023
|
Veena Rao Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,675
+40.23%
|
-
|